A cellular study also demonstrated that PLCβ1 expression levels in oligodendrocytes were higher than that in astrocytes [20], a finding that may be useful in interpreting the clinical outcome whereby oligodendroglioma patients usually have a better prognosis than astrocytoma patients. Here, PLCB1 is linked to astrocytoma (excluding glioblastoma).